Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if an investigational drug called MORAb-003 is
useful by itself or when used with other approved cancer drugs in treating women with ovarian
cancer. MORAb-003 is a monoclonal antibody directed against an antigen on most ovarian
cancers.